Outcomes Following Cochlear Osia 2 Implantation in Patients Ages 5–11 Years: A Multi‐Center Trial
This study was part of a Multi-center prospective trial, submitted to and approved by the FDA (Clinicaltrials.gov number: NCT05000931; FDA IDE number: G2000325).
Authors
- Alejandro Rivas (ORCID: https://orcid.org/0000-0001-6397-0854)
- Viral D. Tejani (ORCID: https://orcid.org/0000-0001-7585-9619)
- John A. Germiller (ORCID: https://orcid.org/0000-0002-6416-3015)
- Yi‐Chun Carol Liu (ORCID: https://orcid.org/0000-0002-1575-0571)
- Sarah E. Mowry (ORCID: https://orcid.org/0000-0003-2366-3205)
- Kay W. Chang
- Sheldon Stevens (ORCID: https://orcid.org/0009-0003-6755-3654)
- Daniela Carvalho (ORCID: https://orcid.org/0000-0002-7062-8843)
- Abby Meyer
Institutions
- Barrow Neurological Institute (US)
- Lucile Packard Children's Hospital (US)
- Children's Hospital of Philadelphia (US)
- University Hospitals of Cleveland (US)
- University of California San Diego (US)
- Children's Minnesota (US)
- Texas Children's Hospital (US)
- Stanford University (US)
Publication Details
- Journal
- The Laryngoscope
- Published
- 2025-04-11
- DOI
- https://doi.org/10.1002/lary.32159
- Citations
- 5
- Primary Topic
- Hearing Loss and Rehabilitation
- Type
- article
- Field-Weighted Citation Impact
- 7.16